Dark mode is part of the Premium plan.

It is included in the free trial.

Sign inSee Premium
Create a free account
Create a free account

Feeds › Insider trades

Insider trades

Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.

About this data
What it is
When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
Who files it
The insider, usually through the company, within two business days of the trade.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.

All of this comes from public filings.

Source and freshness · Information, not investment advice (disclaimer).

Open-market trades per day, last 30 days

05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0
05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0

Purchases Sales

By trade date. Insiders have two business days to file, so the most recent days fill in later.

Latest open-market insider trades

Reset

Showing: ticker VOR

Latest open-market insider trades
TradedInsiderCompanyTypeSharesPriceValueFiling
Jul 16, 2026Rajeev M. Shah
10% owner
VOR
Vor Biopharma Inc.
Sale213$19.75$4,207 SaleForm 4 ↗
Apr 22, 2026Rajeev M. Shah
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale165,150$15.77$2.6M SaleForm 4 ↗
Apr 20, 2026Ra Capital Management, L.P.
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale171,963$15.77$2.7M SaleForm 4 ↗
Apr 17, 2026Ra Capital Management, L.P.
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale458,411$16.28$7.5M SaleForm 4 ↗
Apr 15, 2026Ra Capital Management, L.P.
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale53,644$16.01$858.8K SaleForm 4 ↗
Apr 14, 2026Ra Capital Management, L.P.
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale153,735$15.97$2.5M SaleForm 4 ↗
Apr 13, 2026Ra Capital Management, L.P.
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale530,610$16.15$8.6M SaleForm 4 ↗
Apr 10, 2026Rajeev M. Shah
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale828$15.75$13.0K SaleForm 4 ↗
Apr 9, 2026Rajeev M. Shah
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale135,201$16.59$2.2M SaleForm 4 ↗
Apr 8, 2026Rajeev M. Shah
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale130,862$16.91$2.2M SaleForm 4 ↗
Apr 8, 2026Rajeev M. Shah
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale353,242$16.32$5.8M SaleForm 4 ↗
Apr 6, 2026Peter Kolchinsky
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale6,775$18.50$125.3K SaleForm 4 ↗
Apr 6, 2026Peter Kolchinsky
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale44,728$17.31$774.2K SaleForm 4 ↗
Apr 6, 2026Peter Kolchinsky
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale537,754$16.51$8.9M SaleForm 4 ↗
Apr 2, 2026Peter Kolchinsky
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale1,525$19.06$29.1K SaleForm 4 ↗
Apr 2, 2026Peter Kolchinsky
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale258,475$18.23$4.7M SaleForm 4 ↗
Oct 30, 2025Peter Kolchinsky
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale24,579$25.12$617.4K SaleForm 4 ↗
Oct 29, 2025Peter Kolchinsky
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale251,518$25.22$6.3M SaleForm 4 ↗
Oct 28, 2025Peter Kolchinsky
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale36,483$28.18$1.0M SaleForm 4 ↗
Oct 28, 2025Peter Kolchinsky
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale87,828$27.10$2.4M SaleForm 4 ↗
Oct 27, 2025Ra Capital Management, L.P.
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale90,941$28.12$2.6M SaleForm 4 ↗
Oct 24, 2025Ra Capital Management, L.P.
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale53,345$28.01$1.5M SaleForm 4 ↗
Oct 23, 2025Ra Capital Management, L.P.
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale76,880$28.01$2.2M SaleForm 4 ↗
Oct 21, 2025Reprogrammed Interchange LLC
10% owner
VOR
Vor Biopharma Inc.
Sale200$30.08$6,016 SaleForm 4 ↗
Oct 21, 2025RA Capital Nexus Fund, L.P.
Director
VOR
Vor Biopharma Inc.
Sale25,027$28.11$703.5K SaleForm 4 ↗
Oct 20, 2025Reprogrammed Interchange LLC
10% owner
VOR
Vor Biopharma Inc.
Sale11,616$30.05$349.1K SaleForm 4 ↗
Oct 20, 2025RA Capital Nexus Fund, L.P.
Director
VOR
Vor Biopharma Inc.
Sale1,287$30.12$38.8K SaleForm 4 ↗
Oct 20, 2025RA Capital Nexus Fund, L.P.
Director
VOR
Vor Biopharma Inc.
Sale6,553$30.12$197.4K SaleForm 4 ↗
Oct 20, 2025RA Capital Nexus Fund, L.P.
Director
VOR
Vor Biopharma Inc.
Sale13,817$29.63$409.4K SaleForm 4 ↗
Oct 20, 2025RA Capital Nexus Fund, L.P.
Director
VOR
Vor Biopharma Inc.
Sale70,366$29.63$2.1M SaleForm 4 ↗
Oct 17, 2025Reprogrammed Interchange LLC
10% owner
VOR
Vor Biopharma Inc.
Sale1,028$31.00$31.9K SaleForm 4 ↗
Oct 17, 2025Reprogrammed Interchange LLC
10% owner
VOR
Vor Biopharma Inc.
Sale24,689$30.22$746.1K SaleForm 4 ↗
Oct 17, 2025Rajeev M. Shah
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale2,492$31.00$77.3K SaleForm 4 ↗
Oct 17, 2025Rajeev M. Shah
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale12,691$31.00$393.4K SaleForm 4 ↗
Oct 17, 2025Rajeev M. Shah
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale6,040$30.28$182.9K SaleForm 4 ↗
Oct 17, 2025Rajeev M. Shah
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale30,758$30.28$931.4K SaleForm 4 ↗
Oct 17, 2025Rajeev M. Shah
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale34,284$29.12$998.4K SaleForm 4 ↗
Oct 17, 2025Rajeev M. Shah
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale174,594$29.12$5.1M SaleForm 4 ↗
Oct 16, 2025Reprogrammed Interchange LLC
10% owner
VOR
Vor Biopharma Inc.
Sale2,021$30.45$61.5K SaleForm 4 ↗
Oct 16, 2025Rajeev M. Shah
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale4$31.35$125 SaleForm 4 ↗
Oct 16, 2025Rajeev M. Shah
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale20$31.35$627 SaleForm 4 ↗
Oct 16, 2025Rajeev M. Shah
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale3,108$30.36$94.4K SaleForm 4 ↗
Oct 16, 2025Rajeev M. Shah
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale15,826$30.36$480.5K SaleForm 4 ↗
Oct 16, 2025Rajeev M. Shah
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale21,804$29.32$639.3K SaleForm 4 ↗
Oct 16, 2025Rajeev M. Shah
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale111,041$29.32$3.3M SaleForm 4 ↗
Oct 15, 2025Reprogrammed Interchange LLC
10% owner
VOR
Vor Biopharma Inc.
Sale7,894$32.77$258.7K SaleForm 4 ↗
Oct 15, 2025Reprogrammed Interchange LLC
10% owner
VOR
Vor Biopharma Inc.
Sale48,910$32.05$1.6M SaleForm 4 ↗
Oct 15, 2025Reprogrammed Interchange LLC
10% owner
VOR
Vor Biopharma Inc.
Sale14,851$31.05$461.1K SaleForm 4 ↗
Oct 15, 2025Rajeev M. Shah
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale46$31.17$1,434 SaleForm 4 ↗
Oct 15, 2025Rajeev M. Shah
Director, 10% owner
VOR
Vor Biopharma Inc.
Sale234$31.17$7,294 SaleForm 4 ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:21 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances